Overview of cell death signaling pathways

被引:1050
作者
Jin, ZY
El-Deiry, WS
机构
[1] Univ Penn, Sch Med, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
关键词
apoptosis; death receptor; mitochondria; caspase; cancer;
D O I
10.4161/cbt.4.2.1508
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Apoptosis plays an important role in development and maintenance of tissue homeostasis. Intensive efforts have been made to explore the molecular mechanisms of the apoptotic signaling pathways including the initiation, mediation, execution and regulation of apoptosis. Caspases are central effectors of apoptosis. Cells undergo apoptosis through two major pathways, the extrinsic pathway (death receptor pathway) or the intrinsic pathway (the mitochondrial pathway). Finally, the contents of dead cells are packaged into apoptotic bodies, which are recognized by neighboring cells or macrophages and cleared by phagocytosis. Cellular apoptosis is tightly controlled by a complex regulatory networks including balancing pro-survival signals. De-regulation of apoptosis may lead to pathological disorders such as developmental defects, autoimmune diseases, neurodegeneration or cancer. Increasing attention is being focused on alternative signaling pathways leading to cell death including necrosis, autophagy, and mitotic catastrophe. Understanding of cell death signaling pathways is relevant to understanding cancer and to developing more effective therapeutics.
引用
收藏
页码:139 / 163
页数:25
相关论文
共 344 条
  • [1] Nuclear factor-κ-B:: The enemy within
    Aggarwal, BB
    [J]. CANCER CELL, 2004, 6 (03) : 203 - 208
  • [2] AGGARWAL BB, 2003, NAT REV IMMUNOL, P3
  • [3] Molecular ordering of the initial signaling events of CD95
    Algeciras-Schimnich, A
    Shen, L
    Barnhart, BC
    Murmann, AE
    Burkhardt, JK
    Peter, ME
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (01) : 207 - 220
  • [4] Human ICE/CED-3 protease nomenclature
    Alnemri, ES
    Livingston, DJ
    Nicholson, DW
    Salvesen, G
    Thornberry, NA
    Wong, WW
    Yuan, JY
    [J]. CELL, 1996, 87 (02) : 171 - 171
  • [5] Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis
    Alt, JR
    Greiner, TC
    Cleveland, JL
    Eischen, CM
    [J]. EMBO JOURNAL, 2003, 22 (06) : 1442 - 1450
  • [6] A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
    Ambrosini, G
    Adida, C
    Altieri, DC
    [J]. NATURE MEDICINE, 1997, 3 (08) : 917 - 921
  • [7] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [8] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [9] Targeting death and decoy receptors of the tumour-necrosis factor superfamily
    Ashkenazi, A
    [J]. NATURE REVIEWS CANCER, 2002, 2 (06) : 420 - 430
  • [10] The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment-induced apoptosis
    Bachelder, RE
    Wendt, MA
    Fujita, N
    Tsuruo, T
    Mercurio, AM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) : 34702 - 34707